+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Forecast 2024-2030- Product Image
Global Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904506
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Female Contraceptive Market size was estimated at USD 9.32 billion in 2023, USD 9.91 billion in 2024, and is expected to grow at a CAGR of 6.41% to reach USD 14.40 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Female Contraceptive Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Female Contraceptive Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Female Contraceptive Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Agile Therapeutics, Amgen Inc., Ansell Ltd., Bayer AG, Cipla Limited, Cupid Limited, HLL Lifecare Limited, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., Merck & Co., Inc., Mithra Pharmaceuticals S.A., Pfizer Inc., and The Cooper Companies, Inc.

Market Segmentation & Coverage

This research report categorizes the Female Contraceptive Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Contraceptive Drug
    • Contraceptive Injections
    • Contraceptive Pills
      • Hormonal Pills
      • Non-Hormonal Pills
    • Spermicides
    • Topical Contraceptives
  • Contraceptive Devices
    • Contraceptive Patches
    • Contraceptive Sponges
    • Diaphragms & Caps
    • Female Condoms
    • Intra Uterine Contraceptive Devices
    • Sub-Dermal Contraceptive Implants
    • Vaginal Rings
  • Distribution Channel
    • Clinic
    • Hospital Pharmacy
    • Independent Pharmacy
    • Online Platform
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Female Contraceptive Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Female Contraceptive Market?
  3. What are the technology trends and regulatory frameworks in the Female Contraceptive Market?
  4. What is the market share of the leading vendors in the Female Contraceptive Market?
  5. Which modes and strategic moves are suitable for entering the Female Contraceptive Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Female Contraceptive Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
5.1.1.3. Multiple types and ease of availability of contraceptives
5.1.2. Restraints
5.1.2.1. Side effects of contraceptive drugs
5.1.3. Opportunities
5.1.3.1. Availability of contraceptives method such as Sino-Implants and novel contraceptive
5.1.3.2. Government and non-government organizations supporting programs to encourage contraception in emerging economies
5.1.4. Challenges
5.1.4.1. Social stigma and misconceptions about different contraceptives
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Female Contraceptive Market, by Contraceptive Drug
6.1. Introduction
6.2. Contraceptive Injections
6.3. Contraceptive Pills
6.4.1. Hormonal Pills
6.4.2. Non-Hormonal Pills
6.4. Spermicides
6.5. Topical Contraceptives
7. Female Contraceptive Market, by Contraceptive Devices
7.1. Introduction
7.2. Contraceptive Patches
7.3. Contraceptive Sponges
7.4. Diaphragms & Caps
7.5. Female Condoms
7.6. Intra Uterine Contraceptive Devices
7.7. Sub-Dermal Contraceptive Implants
7.8. Vaginal Rings
8. Female Contraceptive Market, by Distribution Channel
8.1. Introduction
8.2. Clinic
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform
9. Americas Female Contraceptive Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Female Contraceptive Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Female Contraceptive Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Afaxys Pharma, LLC
13.1.3. Agile Therapeutics
13.1.4. Amgen Inc.
13.1.5. Ansell Ltd.
13.1.6. Bayer AG
13.1.7. Cipla Limited
13.1.8. Cupid Limited
13.1.9. HLL Lifecare Limited
13.1.10. Johnson & Johnson Services, Inc.
13.1.11. Mankind Pharma Ltd.
13.1.12. Merck & Co., Inc.
13.1.13. Mithra Pharmaceuticals S.A.
13.1.14. Pfizer Inc.
13.1.15. The Cooper Companies, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. FEMALE CONTRACEPTIVE MARKET RESEARCH PROCESS
FIGURE 2. FEMALE CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
FIGURE 3. FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FEMALE CONTRACEPTIVE MARKET DYNAMICS
FIGURE 7. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2023 VS 2030 (%)
FIGURE 8. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2023 VS 2030 (%)
FIGURE 10. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. FEMALE CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 6. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 9. FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 14. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS & CAPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 40. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 41. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 42. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 44. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 46. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 62. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 63. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 64. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 66. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 67. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 68. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 74. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 75. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 76. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 98. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 99. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 100. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 111. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 112. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 113. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 115. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 116. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 117. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 119. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 120. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 121. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 123. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 125. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 127. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 129. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 135. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 136. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 137. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 147. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 148. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 149. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 151. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 152. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 153. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 155. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 156. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 157. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 171. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 173. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 183. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 184. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 185. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 195. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 196. FEMALE CONTRACEPTIVE MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Agile Therapeutics
  • Amgen Inc.
  • Ansell Ltd.
  • Bayer AG
  • Cipla Limited
  • Cupid Limited
  • HLL Lifecare Limited
  • Johnson & Johnson Services, Inc.
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals S.A.
  • Pfizer Inc.
  • The Cooper Companies, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 9.91 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.4 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Forecast 2024-2030 - Product Image

Global Contraceptive Market by Product (Devices, Drugs), Gender (Female Contraceptive, Male Contraceptive), Method, Distribution - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Female Contraceptive - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Female Contraceptive - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 112 Pages
  • Global
From
Global Female Contraceptive Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Female Contraceptive Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Global Contraceptive Market Analysis & Forecast to 2023-2033: Market By Product; By Gender; By Distribution Channel; and By Region - Product Image

Global Contraceptive Market Analysis & Forecast to 2023-2033: Market By Product; By Gender; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Contraceptive Drugs and Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Image

Contraceptive Drugs and Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • 111 Pages
  • Global
From

About the Female Contraceptive Market

The Female Contraceptive market is an important part of Women's Health, providing women with the ability to control their reproductive health. Contraceptives are used to prevent pregnancy, and can be divided into two main categories: hormonal and non-hormonal. Hormonal contraceptives, such as the pill, patch, and ring, use hormones to prevent ovulation and fertilization. Non-hormonal contraceptives, such as condoms, diaphragms, and spermicides, work by blocking sperm from entering the uterus. In addition to preventing pregnancy, contraceptives can also be used to treat a variety of conditions, such as endometriosis, polycystic ovary syndrome, and acne. Contraceptives can also be used to regulate menstrual cycles and reduce the risk of certain cancers. Some companies in the Female Contraceptive market include Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.